CSF BiosciencesCSF Biosciences
CB

CSF Biosciences

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

2022Inactive

About

CSF Biosciences is a biotechnology startup focused on advancing protein engineering and directed evolution. Their proprietary platform aims to accelerate the discovery and development of novel protein-based therapeutics by enabling rapid, high-throughput screening and optimization of protein variants.

Technology stack

detected 2026-05-26
Est. monthly stack spend~$70/mo
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does CSF Biosciences do?

CSF Biosciences is a biotechnology startup focused on advancing protein engineering and directed evolution. Their proprietary platform aims to accelerate the discovery and development of novel protein-based therapeutics by enabling rapid, high-throughput screening and optimization of protein variants.

How much funding has CSF Biosciences raised?

CSF Biosciences has raised a total of $15M in funding. The most recent round on record is Series A.

Where is CSF Biosciences headquartered?

CSF Biosciences is headquartered in Cambridge, United States.

When was CSF Biosciences founded?

CSF Biosciences was founded in 2022.

What industry does CSF Biosciences operate in?

CSF Biosciences operates in Biotech, Drug Discovery, Protein Engineering, Directed Evolution, Therapeutics, Genomics.

What is CSF Biosciences's current status?

CSF Biosciences's current operating status is: Inactive.